Terbium
Active ingredient
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Terbium is an element that is not currently approved for any therapeutic uses in humans. It belongs to the lanthanide series of rare-earth elements. As of the latest information available, there are no approved drug products containing Terbium as an active ingredient for the treatment of any medical condition [1].
The regulatory landscape does not currently list Terbium as having any established drug class or approved indications for use in pharmaceutical products [1]. Consequently, there are no commonly recognized brand names associated with Terbium for medicinal purposes, nor are there adverse event reports or top reactions to report for this substance in a medical context [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | July 26, 2023 |
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]FDA DailyMed · 01662ca5-df5f-a8… · revised July 26, 2023 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.